跳至主要内容
临床试验/NCT05802979
NCT05802979进行中(未招募)3 期

Analgesic Efficacy of Ketamine Versus Neostigmine as Adjuvants to Bupivacaine During Ultrasound-guided Serratus Anterior Plane Block in Modified Radical Mastectomy

Ain Shams University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
analgsic consumption

研究概览

简要总结

This study is designed to investigate the analgesic efficacy of ketamine compared to neostigmine as adjuvants to LA in ultrasound guided Serratus Anterior Plane Block (SAPB) in patients undergoing Modified Radical Mastectomy. We hypothesize that adding either neostigmine or ketamine to bupivacaine in ultrasound guided SAPB would increase the total analgesic duration and decrease the total 24 hr postoperative Nalbuphine consumption compared to SAPB with bupivacaine only. The first 24 hr of postoperative Nalbuphine consumption is set as the primary outcome. The time of the first request of analgesia, pain score, side effects of drugs and patient hemodynamics are set as the secondary outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA II patients, BMI< 35Kg/m2

排除标准

  • refusal of participation, ASA III or above, history of allergy to the study drugs, BMI> 35kg/m2, coagulation disorders, psychiatric illnesses that may interfere with pain evaluation, epileptic patients, patients with tachy or brady arrthymias, patients with increased intracranial tension

研究组 & 干预措施

group 1

Active Comparator

consists of patients receiving Serratus anterior plane block using Bupivacaine + Ketamine.

干预措施: Adjuvants, Anesthesia (Drug)

group 2

Active Comparator

consists of patients receiving Serratus anterior plane block using Bupivacaine + neostigmine.

干预措施: Adjuvants, Anesthesia (Drug)

group 3

Placebo Comparator

consists of patients receiving Serratus anterior plane block using Bupivacaine + normal saline.

干预措施: Adjuvants, Anesthesia (Drug)

结局指标

主要结局

analgsic consumption

时间窗: first 24 hours postoperative

total amount of consumed nalbuphine

次要结局

  • time to rescue analgesia(first 24 hours postoperative)
  • pain scores(first 24 hours postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aya Hisham

Lecturer of Anesthesia

Ain Shams University

研究点 (1)

Loading locations...

相似试验